ACE2 and acute respiratory distress syndrome: By reducing the activity of ACE2, SARS-CoV-2 may cause a significant advantage of angiotensin 2 over angiotensin (1-7), which, in the light of the data presented above, may adversely affect many functions of the human body, for example lung function, causing acute respiratory failure (ARDS).